The other clinical parameters including age, albumin, tumor location, M stage, total dose > 60 Gy, single dose, GTV volume, chemotherapy, treatment response (PR+CR vs. SD+PD), smoking history, diabetes, and hypertension were not significant for their association with EF. This evidence concerns the gene ALB and Hypertension.